Amy Jennings is a member of GentiBio Scientific Advisory Board. Amy is the Founder and Principal Regulatory Consultant at RegPath LLC, which provides product development and regulatory support to small biotechnology companies. Prior to founding RegPath, Amy was the SVP, Head of Regulatory Affairs at Casebia Therapeutics and served as the cross-functional Project Lead for the autoimmune/tolerance edited T regulatory cell program. Prior to Casebia, She was the SVP, Head of Regulatory at Achillion Pharmaceuticals and, earlier, served as Sanofi’s associate vice president for global regulatory affairs in the company’s North American diabetes program. Before Sanofi, Amy held positions of increasing responsibility at Bristol-Myers Squibb. Dr. Jennings received her B.Sc. in Chemistry from the University of Wisconsin-Madison, her Ph.D. in Biochemistry from The Ohio State University, and was a post-doctoral fellow at the Harvard-affiliated Joslin Diabetes Center.
Amy Jennings, PhD
Principal, RegPath Consulting